SEC Form 4 · accession 0001664708-26-000002
Cardiff Oncology, Inc. · CRDF
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mani Mohindru
Officer — Chief Executive Officer · Director
Period of report
Jun 18, 2026
Accepted (ET)
Jun 22, 2026 · 9:00 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001213037
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 18, 2026 | P | 24,703 | $1.21 | A | 24,703 | D |
Table II — derivative securities
No Table II lines on this filing.